Carcinoid Tumors

• FDA approval · 2022-02-09
  FDA Approved: OCTREOSCAN — Supplemental Application (Curium US LLC)

  FDA documents a supplemental approval application for OCTREOSCAN (Indium-111 pentetreotide) submitted by Curium US LLC.

• FDA approval · 2014-01-30
  FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Sandostatin LAR Depot (octreotide acetate) submitted by Novartis Pharmaceuticals Corporation. Th…

• FDA approval · 2013-11-12
  FDA Approved: OCTREOTIDE ACETATE — Original Application (Sagent Pharmaceuticals)

  FDA approved Sagent Pharmaceuticals' Original Application for octreotide acetate injectable, a generic form of octreotide. It is approved fo…